Trial reportEuropean journal of heart failure2018
Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF.
Trial report in European journal of heart failure, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05467735 (Above-Knee-High Application of Lower Limb Compression and Its Impact on Clinical Outcome in Patients Hospitalized With Heart Failure Exacerbation.), which is not on this map. Cited by 34 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Above-Knee-High Application of Lower Limb Compression and Its Impact on Clinical Outcome in Patients Hospitalized With Heart Failure Exacerbation.
Who cites it
34 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Incidence and influencing factors of 30-day unplanned readmission in chronic heart failure patients: a systematic review and meta-analysis.Frontiers in cardiovascular medicine · 2025Pooled it
- Heart Failure and All-Cause Hospitalizations in Patients With Heart Failure: A Meta-Analysis.JAMA network open · 2024Pooled it
- Highlights in heart failure.ESC heart failure · 2019Pooled it
- Relation of Volume Overload to Clinical Outcomes in Acute Heart Failure (From ASCEND-HF).The American journal of cardiology · 2018Trial
- Timing-specific factors associated with early, intermediate, and late readmission after heart failure hospitalization.ESC heart failure · 2026Article
- The relationship between discharge destination and rehospitalization in Chinese patients with heart failure: a cohort study.Frontiers in cardiovascular medicine · 2026Article
- Clinical Audit on Follow-Up Time of Patients Admitted With Acute Decompensated Heart Failure.Cureus · 2026Article
- Prognostic Value of Early Rehospitalization in Heart Failure Patients.Journal of clinical medicine · 2025Article
- Predicted Mortality and Cardiology Follow-up Following Heart Failure Hospitalizations Among Veterans Health Administration Patients.Journal of cardiac failure · 2025Article
- Prognostic Impact of Hospitalization-Associated Disability and Care Level in Older Heart Failure Patients - Findings From the J-Proof HF Registry.Circulation reports · 2025Article
- Factors influencing unplanned readmission within 30 days in patients with heart failure and their predictive value: a prospective study.BMC cardiovascular disorders · 2025Article
- Prognostic value of left atrial reverse remodelling in patients hospitalized with acute decompensated heart failure.ESC heart failure · 2024Article
- Characteristics and Factors of 30-Day Readmissions after Hospitalization for Acute Heart Failure in China.Reviews in cardiovascular medicine · 2024Article
- Predictors of All-Cause 30-Day Readmissions in Patients with Heart Failure at an Urban Safety Net Hospital: The Importance of Social Determinants of Health and Mental Health.American journal of medicine open · 2023Article
- Machine learning based readmission and mortality prediction in heart failure patients.Scientific reports · 2023Article
- Prognostic factors of readmission and mortality after first heart failure hospitalization: results from EPICAL2 cohort.ESC heart failure · 2023Article
- Real-Life Data on Readmissions of Worsening Heart Failure Outpatients in a Heart Failure Clinic.Cureus · 2023Article
- Unplanned 30-day readmissions, comorbidity and impact on one-year mortality following incident heart failure hospitalisation in Western Australia, 2001-2015.BMC cardiovascular disorders · 2023Article
- Thirty-day readmission in patients with heart failure with preserved ejection fraction: Insights from the nationwide readmission database.World journal of cardiology · 2022Article
- Trends, Predictors, and Outcomes of 30-Day Readmission With Heart Failure After Transcatheter Aortic Valve Replacement: Insights From the US Nationwide Readmission Database.Journal of the American Heart Association · 2022Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
14 authors.
Funding
Abstract
aimsPatients hospitalized for heart failure (HF) are at high risk for 30-day readmission. This study sought to examine the timings and causes of readmission within 30 days of an HF hospitalization. METHODS AND
resultsTiming and cause of readmission in the ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure) trial were assessed. Early and late readmissions were defined as admissions occurring within 0-7 days and 8-30 days post-discharge, respectively. Patients who died in hospital or remained hospitalized at day 30 post-randomization were excluded. Patients were compared by timing and cause of readmission. Logistic and Cox proportional hazards regression analyses were used to identify independent risk factors for early vs. late readmission and associations with 180-day outcomes. Of the 6584 patients (92%) in the ASCEND-HF population included in this analysis, 751 patients (11%) were readmitted within 30 days for any cause. Overall, 54% of readmissions were for non-HF causes. The median time to rehospitalization was 11 days (interquartile range: 6-18 days) and 33% of rehospitalizations occurred by day 7. Rehospitalization within 30 days was independently associated with increased risk for 180-day all-cause death [hazard ratio (HR) 2.38, 95% confidence interval (CI) 1.93-2.94; P < 0.001]. Risk for 180-day all-cause death did not differ according to early vs. late readmission (HR 0.99, 95% CI 0.67-1.45; P = 0.94).
conclusionsIn this hospitalized HF trial population, a significant majority of 30-day readmissions were for non-HF causes and one-third of readmissions occurred in the first 7 days. Early and late readmissions within the 30-day timeframe were associated with similarly increased risk for death. Continued efforts to optimize multidisciplinary transitional care are warranted to improve rates of early readmission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.